Drug intelligence / Profile preview

CP-010 (Chodang Pharm)

Development stage: Preclinical
Lead developer: Chodang Pharm

Overview

CP-010 is a drug candidate currently under development by Chodang Pharmaceutical Industry, targeting central nervous system (CNS) disorders. As of the latest pipeline updates, the project is in the preclinical research phase. The drug is categorized within the company's portfolio as a 'CNS제제' (CNS preparation/agent). Specific details regarding its molecular structure, biological target, or the exact CNS indication (such as neurodegenerative diseases or psychiatric disorders) have not been publicly disclosed by the developer.

Beyond the preview

Go deeper on CP-010 (Chodang Pharm).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CP-010 (Chodang Pharm).

Explore the full profile